Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

139 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effects of Germline CYP2W1*6 and CYP2B6*6 Single Nucleotide Polymorphisms on Mitotane Treatment in Adrenocortical Carcinoma: A Multicenter ENSAT Study.
Altieri B, Sbiera S, Herterich S, De Francia S, Della Casa S, Calabrese A, Pontecorvi A, Quinkler M, Kienitz T, Mannelli M, Canu L, Angelousi A, Chortis V, Kroiss M, Terzolo M, Fassnacht M, Ronchi CL. Altieri B, et al. Among authors: ronchi cl. Cancers (Basel). 2020 Feb 4;12(2):359. doi: 10.3390/cancers12020359. Cancers (Basel). 2020. PMID: 32033200 Free PMC article.
Targeted Gene Expression Profile Reveals CDK4 as Therapeutic Target for Selected Patients With Adrenocortical Carcinoma.
Liang R, Weigand I, Lippert J, Kircher S, Altieri B, Steinhauer S, Hantel C, Rost S, Rosenwald A, Kroiss M, Fassnacht M, Sbiera S, Ronchi CL. Liang R, et al. Among authors: ronchi cl. Front Endocrinol (Lausanne). 2020 Apr 16;11:219. doi: 10.3389/fendo.2020.00219. eCollection 2020. Front Endocrinol (Lausanne). 2020. PMID: 32373071 Free PMC article.
ENSAT registry-based randomized clinical trials for adrenocortical carcinoma.
Crona J, Baudin E, Terzolo M, Chrisoulidou A, Angelousi A, Ronchi CL, Oliveira CL, Nieveen van Dijkum EJM, Ceccato F, Borson-Chazot F, Reimondo G, Tiberi GAM, Ettaieb H, Kiriakopoulos A, Canu L, Kastelan D, Osher E, Yiannakopoulou E, Arnaldi G, Assié G, Paiva I, Bourdeau I, Newell-Price J, Nowak KM, Romero MT, De Martino MC, Bugalho MJ, Sherlock M, Vantyghem MC, Dennedy MC, Loli P, Rodien P, Feelders R, de Krijger R, Van Slycke S, Aylwin S, Morelli V, Vroonen L, Shafigullina Z, Bancos I, Trofimiuk-Müldner M, Quinkler M, Luconi M, Kroiss M, Naruse M, Igaz P, Mihai R, Della Casa S, Berruti A, Fassnacht M, Beuschlein F. Crona J, et al. Among authors: ronchi cl. Eur J Endocrinol. 2021 Feb;184(2):R51-R59. doi: 10.1530/EJE-20-0800. Eur J Endocrinol. 2021. PMID: 33166271 Free article. Review.
The role of molecular profiling in adrenocortical carcinoma.
Lippert J, Fassnacht M, Ronchi CL. Lippert J, et al. Among authors: ronchi cl. Clin Endocrinol (Oxf). 2022 Oct;97(4):460-472. doi: 10.1111/cen.14629. Epub 2021 Nov 8. Clin Endocrinol (Oxf). 2022. PMID: 34750847 Review.
PLK1 inhibitors as a new targeted treatment for adrenocortical carcinoma.
Warmington E, Smith G, Chortis V, Liang R, Lippert J, Steinhauer S, Landwehr LS, Hantel C, Kiseljak-Vassiliades K, Wierman ME, Altieri B, Foster PA, Ronchi CL. Warmington E, et al. Among authors: ronchi cl. Endocr Connect. 2023 Dec 14;13(1):e230403. doi: 10.1530/EC-23-0403. Print 2024 Jan 1. Endocr Connect. 2023. PMID: 37992487 Free PMC article.
Next-generation therapies for adrenocortical carcinoma.
Altieri B, Ronchi CL, Kroiss M, Fassnacht M. Altieri B, et al. Among authors: ronchi cl. Best Pract Res Clin Endocrinol Metab. 2020 May;34(3):101434. doi: 10.1016/j.beem.2020.101434. Epub 2020 Jun 18. Best Pract Res Clin Endocrinol Metab. 2020. PMID: 32622829 Review.
139 results